Moneycontrol PRO
HomeNewsBusinessStocksMax Healthcare Institute shares rise 1.54% amid high volume

Max Healthcare Institute shares rise 1.54% amid high volume

With the stock currently trading at Rs 1,276.80, Max Healthcare Institute Limited has shown a positive trend in today's session, backed by high volume and positive financial performance.

July 29, 2025 / 15:41 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
paradeep phosphates
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shares of Max Healthcare Institute Limited gained 1.54% to trade at Rs 1,276.80 in Tuesday's session, witnessing a surge in volume. This increase reflects a positive shift in investor interest. At 3:27 PM, the stock demonstrated notable activity compared to its performance in the previous sessions.

    The stock is trading with high volume on the NSE, indicating increased participation.

    Financial Performance:

    The following table presents the consolidated quarterly financial performance of Max Healthcare Institute Limited:

    HeadingMar 2024Jun 2024Sep 2024Dec 2024Mar 2025
    RevenueRs 1,422.90 CroreRs 1,542.95 CroreRs 1,707.46 CroreRs 1,868.31 CroreRs 1,909.74 Crore
    Net ProfitRs 251.54 CroreRs 236.27 CroreRs 281.81 CroreRs 238.80 CroreRs 319.00 Crore
    EPS2.592.432.902.463.28

    The revenue for the quarter-ending March 2025 stood at Rs 1,909.74 Crore, compared to Rs 1,422.90 Crore in March 2024. Net profit for the quarter-ending March 2025 was Rs 319.00 Crore, up from Rs 251.54 Crore in the same quarter last year. Earnings per share (EPS) increased to Rs 3.28 for March 2025 from Rs 2.59 in March 2024.

    The table below shows the consolidated yearly financial performance:

    Heading20212022202320242025
    RevenueRs 2,504.67 CroreRs 3,931.46 CroreRs 4,562.60 CroreRs 5,406.02 CroreRs 7,028.46 Crore
    Net ProfitRs -114.50 CroreRs 605.05 CroreRs 1,103.51 CroreRs 1,057.64 CroreRs 1,075.88 Crore
    EPS-1.596.2511.3810.8911.07
    BVPS58.3764.7976.3186.5196.50
    ROE-2.439.6314.8912.5711.46
    Debt to Equity0.160.120.080.140.27

    The company's revenue for the year ending March 2025 was Rs 7,028.46 Crore, a significant increase from Rs 5,406.02 Crore in March 2024. The net profit for the year ending March 2025 was Rs 1,075.88 Crore, compared to Rs 1,057.64 Crore in the previous year. The Earnings Per Share (EPS) stood at Rs 11.07 for March 2025, slightly up from Rs 10.89 in March 2024.

    Annual Income Statement:

    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    SalesRs 7,028 CroreRs 5,406 CroreRs 4,562 CroreRs 3,931 CroreRs 2,504 Crore
    Other IncomeRs 155 CroreRs 178 CroreRs 139 CroreRs 127 CroreRs 114 Crore
    Total IncomeRs 7,184 CroreRs 5,584 CroreRs 4,701 CroreRs 4,058 CroreRs 2,619 Crore
    Total ExpenditureRs 5,612 CroreRs 4,158 CroreRs 3,554 CroreRs 3,219 CroreRs 2,508 Crore
    EBITRs 1,571 CroreRs 1,425 CroreRs 1,147 CroreRs 839 CroreRs 110 Crore
    InterestRs 165 CroreRs 59 CroreRs 83 CroreRs 100 CroreRs 179 Crore
    TaxRs 330 CroreRs 307 CroreRs -39 CroreRs 133 CroreRs 45 Crore
    Net ProfitRs 1,075 CroreRs 1,057 CroreRs 1,103 CroreRs 605 CroreRs -114 Crore

    The sales for March 2025 increased to Rs 7,028 Crore from Rs 5,406 Crore in March 2024. The total income also rose to Rs 7,184 Crore in March 2025 compared to Rs 5,584 Crore in the previous year.

    Quarterly Income Statement:

    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    SalesRs 1,909 CroreRs 1,868 CroreRs 1,707 CroreRs 1,542 CroreRs 1,422 Crore
    Other IncomeRs 46 CroreRs 33 CroreRs 40 CroreRs 34 CroreRs 45 Crore
    Total IncomeRs 1,956 CroreRs 1,901 CroreRs 1,748 CroreRs 1,577 CroreRs 1,468 Crore
    Total ExpenditureRs 1,498 CroreRs 1,540 CroreRs 1,341 CroreRs 1,232 CroreRs 1,111 Crore
    EBITRs 457 CroreRs 361 CroreRs 407 CroreRs 345 CroreRs 356 Crore
    InterestRs 55 CroreRs 52 CroreRs 33 CroreRs 23 CroreRs 20 Crore
    TaxRs 83 CroreRs 70 CroreRs 91 CroreRs 85 CroreRs 84 Crore
    Net ProfitRs 319 CroreRs 238 CroreRs 281 CroreRs 236 CroreRs 251 Crore

    The sales for the quarter ending March 2025 were Rs 1,909 Crore compared to Rs 1,422 Crore for the quarter ending March 2024. Similarly, the net profit for the quarter ending March 2025 was Rs 319 Crore, while it was Rs 251 Crore for the quarter ending March 2024.

    Cash Flow:

    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Operating ActivitiesRs 1,459 CroreRs 1,121 CroreRs 1,209 CroreRs 748 CroreRs 117 Crore
    Investing ActivitiesRs -1,631 CroreRs -1,285 CroreRs -1,187 CroreRs -771 CroreRs -73 Crore
    Financing ActivitiesRs -163 CroreRs -263 CroreRs -288 CroreRs -294 CroreRs 191 Crore
    OthersRs 17 CroreRs 32 CroreRs 0 CroreRs 0 CroreRs 279 Crore
    Net Cash FlowRs -318 CroreRs -394 CroreRs -266 CroreRs -317 CroreRs 515 Crore
    Balance Sheet:
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Share CapitalRs 972 CroreRs 971 CroreRs 970 CroreRs 969 CroreRs 965 Crore
    Reserves & SurplusRs 8,408 CroreRs 7,368 CroreRs 6,397 CroreRs 5,290 CroreRs 4,646 Crore
    Current LiabilitiesRs 1,813 CroreRs 1,248 CroreRs 1,045 CroreRs 757 CroreRs 776 Crore
    Other LiabilitiesRs 4,019 CroreRs 2,410 CroreRs 1,688 CroreRs 2,171 CroreRs 2,155 Crore
    Total LiabilitiesRs 15,214 CroreRs 11,999 CroreRs 10,101 CroreRs 9,189 CroreRs 8,544 Crore
    Fixed AssetsRs 8,922 CroreRs 6,384 CroreRs 4,836 CroreRs 4,714 CroreRs 4,108 Crore
    Current AssetsRs 1,592 CroreRs 1,706 CroreRs 1,943 CroreRs 1,000 CroreRs 1,124 Crore
    Other AssetsRs 4,699 CroreRs 3,909 CroreRs 3,322 CroreRs 3,474 CroreRs 3,311 Crore
    Total AssetsRs 15,214 CroreRs 11,999 CroreRs 10,101 CroreRs 9,189 CroreRs 8,544 Crore
    Contingent LiabilitiesRs 1,374 CroreRs 1,169 CroreRs 326 CroreRs 515 CroreRs 388 Crore
    Financial Ratios:
    RatioMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Basic EPS (Rs.)11.0710.8911.386.25-1.59
    Diluted Eps (Rs.)11.0110.8411.366.24-1.59
    Book Value /Share (Rs.)96.5086.5176.3164.7958.37
    Dividend/Share (Rs.)1.501.500.000.000.00
    Face Value1010101010
    Gross Profit Margin (%)28.5130.8930.2427.2120.70
    Operating Margin (%)23.4026.3625.1521.5813.75
    Net Profit Margin (%)15.3019.5624.1815.38-4.57
    Return on Networth / Equity (%)11.4612.5714.899.63-2.43
    ROCE (%)12.2713.2512.6710.064.43
    Return On Assets (%)7.078.8110.926.58-1.60
    Current Ratio (X)0.881.371.861.321.45
    Quick Ratio (X)0.821.301.791.241.38
    Debt to Equity (x)0.270.140.080.120.16
    Interest Coverage Ratios (X)12.1527.8916.4510.611.92
    Asset Turnover Ratio (%)0.520.490.220.2229.31
    Inventory Turnover Ratio (X)74.280.000.000.0046.56
    3 Yr CAGR Sales (%)33.7146.91107.566,170.144,904.67
    3 Yr CAGR Net Profit (%)33.35203.92824.542,359.78970.05
    P/E (x)99.0975.2938.7655.62-129.40
    P/B (x)11.379.485.785.353.53
    EV/EBITDA (x)54.0947.7730.3831.6538.85
    P/S (x)15.1714.759.388.567.95
    Corporate Actions:

    Max Healthcare Institute Limited announced a final dividend of Rs 1.50 per share (15%) with effective date as 04 Jul, 2025.

    Moneycontrol analysis, as of 2025-07-23, suggests a bullish sentiment for the stock.

    With the stock currently trading at Rs 1,274.30, Max Healthcare Institute Limited has shown a positive trend in today's session, backed by high volume and positive financial performance.

    Alpha Desk
    first published: Jul 29, 2025 03:41 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347